# Zhangjiagang Onechip Bio-Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhangjiagang-onechip-bio-technology-co

- Industry: Semiconductors
- Headquarters: Suzhou, China
- Website: www.one-chip.com
- Total disclosed funding: $37M
- Latest round: Series B (Sep 28, 2023)
- Investors on record: 8

## About

Founded in 2014 and based in Suzhou, China, Zhangjiagang Onechip Bio-Technology Co., Ltd.is a semiconductor chip manufacturing company that focuses on the research and development of semiconductor chips and related smart devices. The company was honored with 2020-2021 Future Medical 100, China's Top 100 Innovative Medical Devices, 2018 Suzhou Top 100 Enterprises, 2019 Hibiscus Top Entrepreneurial Team, and 2019 China International Software Cooperation Fair "Most Valuable Investment Award". It has cooperated with Midea, HITGEN, Sansure Biotech, and iGeneTech and other enterprises. The company has nearly 30,000 square meters of R&D and manufacturing facilities in Suzhou and Chengdu. In September 2023, it raised series B+ funding.

Zhangjiagang Onechip Bio-Technology Co., Ltd.'s product can be categorized into 3 series, which are COVID-19 Testing, Precision Genetic Testing, and Intelligent Environment Detection. Products within include COVID-19 Test Cartridge, Reader for Virus Test, Semiconductor Digital PCR, Small Gene Sequencer and Drinking Water Detection Module. The products can be used for the detection of various diseases and medication guidance.

## Funding rounds

- Series B, Sep 28, 2023, $14M — Dianke Venture, Chengdu Future Medical City Investment
- Series B, Apr 19, 2022, $23M — Qiming Venture Partners, MPC, Xiamen C&D Emerging Industry Equity Investment, Zhangjiagang Phoenix Technology Development
- Series B, Jan 4, 2021 — MPC
- Series A, Apr 27, 2017 — Powercloud
- Angel, May 27, 2016 — Initial Capital

## Investors

- Initial Capital — Angel
- Powercloud (https://capitalatlas.ai/funds/powercloud) — Series A
- MPC — Series B
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B
- Xiamen C&D Emerging Industry Equity Investment (https://capitalatlas.ai/funds/xiamen-c-d-emerging-industry-equity-investment) — Series B
- Zhangjiagang Phoenix Technology Development — Series B
- Dianke Venture (https://capitalatlas.ai/funds/dianke-venture) — Series B
- Chengdu Future Medical City Investment — Series B